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Affibodies are a type of small protein that can be designed to bind with high affinity to 
a researcher’s protein of choice. They have been utilized in a variety of different 
applications, including therapeutics, in vivo imaging, and biotechnological applications. 
Affibody molecules that are specific to a protein target can be selected for using a 
library of affibody molecules displayed on phage. In this study, a library of affibody 
molecules displayed on M13 bacteriophage was used to probe affibody/snake venom 
interactions. This particular library was developed by New England Biolabs and was 
used to pan against Western diamond back rattlesnake (Crotalus atrox) and Western 
cottonmouth (Agkistrodon piscivorus leucostoma) venoms. By performing the panning 
procedure of the affibody phage display library against snake venom, we hope to 
determine which affibodies have an optimal affinity for the venoms. By identifying 
affibody molecules that have affinity for snake venom proteins, we hope to perform 






Each year in the United States, 7000-8000 people are bitten by venomous snakes, which is a 
physically painful and financially costly experience which may even lead to death. The 
Crotalinae subfamily of pit vipers, which includes rattlesnakes, copperheads, and water 
moccasins, are commonly found in many parts of the U. S., including Texas. CroFab, the 
current antivenom for pit viper snake bites in the U. S., is derived from antibody fragments 
harvested from sheep and effectively treats most snake bites, but there are some limitations 
to the antivenom. In order to expand our knowledge of snake venoms and possibly open the 
door to new antivenom options, an affibody phage display library will be used to develop and 
identify affibody molecules that specifically target Crotalid snake venom proteins. In this 
project, we will be using an affibody phage display library developed by New England Biolabs 
to pan against Western diamondback rattlesnake (Crotalus atrox) venom.
Affibodies are randomized proteins based on the Z-domain of S. aureus Protein A 
and are widely used in phage display experiments to select subnanomolar binders 
to various targets. Their structure is comprised of a three-helix bundle of 58 amino 
acids, with a molecular weight of 6 kDa.  
The displaying of proteins or peptides on the phage surfaces, or phage display, has 
been used for a variety of different applications ranging from drug development1 to 
materials science.2 Because of the link between the phage DNA and the protein 
encoded on its surface, phage display is a powerful screening tool. Here, we 
propose to use this tool as method for studying affibody/snake venom interactions. 
Affibody molecule libraries attached to phage have also been used in other 
applications.3
USER technology (NEB) was used to construct an Affibody library of 1x109
complexity using a variant of the phage display cloning vector M13KE (NEB) with a 
G6813A mutation (for genetic stability) in the 5’ UTR of gII, and a synthetic insert 
containing the affibody gene with 13 randomized codons (each NNK, where N is 
equimolar G,A,T,C; and K is equimolar G,T). Through this method, a partially 
randomized DNA segment encoding the affibody protein was added to the N-
terminus of gene III, which encodes pIII. 
SNAKE VENOM PROTEINS
The venom used in our experiment was isolated from the Western Diamondback Rattlesnake, Crotalus 
atrox, a crotalid commonly found in Texas. The proteome of this venom includes 69.5% snake venom 
metalloproteinases (SVMP) and serine proteinases, 25.8% medium-size disintegrin, PLA(2), cysteine-rich 
secretory protein, and l-amino acid oxidase, and 4.7% vasoactive peptides, endogenous inhibitor of SVMP, 
and C-type lectin-like proteins. This composition potentially explains the cytotoxic, myotoxic, hemotoxic, 
and hemorrhagic effects evoked by C. atrox envenomation.4 This snake venom from this species was 
purchased from the National Natural Toxins Research Center at Texas A&M Kingsville. 
First, the affibody phage display library was panned against snake venom. We coated a polystyrene plate with 
a snake venom solution. After incubating the snake venom overnight, unbound venom was washed away. To 
the coated plate, we added the affibody phage display library.  After incubating for 30 minutes, unbound 
phage were washed from the plate, leaving the phage expressing affibody molecules that bound to the snake 
venom on the plate. The phage selected during this first round of panning was eluted and amplified. This 
amplified phage was titered by counting phage plaques, or sites of infection, on a lawn of the ⍺-
complementing strain E.coli ER2738. The amplified phage from each round was then used in the next round 
of selection for further amplification. Three rounds of panning were performed. An ELISA assay will be 
performed on individually selected phage plaques. Affibody phage that are positive on the ELISA will be DNA 
sequenced to determine the affibody expressed. The sequences of the affibody molecules will be panned 
against another venom will be analyzed for similarities and differences that might be helpful to determine 
future directions of the project.
C. atrox: The western diamondback rattlesnake.
http://www.joelsartore.com/galleries/greatest-hits/43/
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As the M13KE is designed to express the lac z alpha domain, blue/white 
screening provides an immediate readout of phage activity when plated on a 
x-gal plate with an alpha complementing bacterial lawn. Blue plaques are 
indicative of M13KE, while white plaques suggest contamination with wild 
type phage. Phage plaques are then selected and amplified for further 
identification. Purified phage DNA is used to verify that the DNA has not been 
mutated. This allows for the identification of the most fit affibody.
To ensure that the proteases with the venom were not degrading the target 
proteins before they could be detected, an HPLC trial was run using 1 mg 
per mL of C. atrox venom in Tris pH 6.8 buffer with and without 1mM EDTA. 
The EDTA acted as a chelating agent to denature the metal containing 
proteases found within the venom. The HPLC traces were recorded at A 254 
and A 260. The traces from each trial were similar across all time periods 
meaning that there was no detectable protein degradation.
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BACTERIOPHAGE
The filamentious bacteriophage M13 is a virus that infects bacteria.  A bacteriophage is composed of a 
single-stranded circular DNA genome surrounded by a protein coat that serves to protect it and also to 
interact with its bacterial cell targets.  The minor coat protein pIII interacts with the F pilus of bacteria and 
is necessary for phage infectivity. The amino terminus of pIII extends into solution so that a protein or 
peptide fusion can be made without interfering with pIII function. Because of the link between the phage 
DNA and the protein encoded on its surface, phage display is a powerful screening tool. 
PRELIMINARY RESULTS













A series of phage panning was utilized to select the affibody with the highest 
affinity for the C. atrox venom. As the panning proceeds, the affibodies with 
weak affinities are washed away and those with high affinities are selected for. 
After 3 rounds of amplification a majority of the G6813A library is still 
displaying affibody, whereas with unmodified M13KE, most of the clones will 





Amplified Phage Titer 
(PFU/10 µL)
1 15 x 103 110 x 109
2 17 x 103 100 x 109
3 376 x 103 71 x 109
Biolabs, N. E. (n.d.). Ph.D.™-7 Phage Display Peptide Library Kit. Retrieved March 30, 2017, from 
https://www.neb.com/products/e8100-phd-7-phage-display-peptide-library-kit
An example of an affibody crystal structure. This in 
particular is the ZHER2 Affibody.
http://www.rcsb.org/pdb/explore.do?structureId=2KZJ
G6813A AFFIBODY PHAGE DISPLAY LIBRARY
Restriction site map of the double stranded plasmid-like of M13KE. The restriction sites Kpn I and Eag 
I are used to prepare the site for insertion to the n terminus of gene III.
M13KE
7223 bp
Insert n-terminal 
fusions to pIII
plaques
